Evidence map›Paper›PMID 40860368›Full record

ArticleFrontiers in cardiovascular medicine2025

Machine learning-based prediction model for recurrence after radiofrequency catheter ablation in patients with atrial fibrillation.

Lujing Nie, Tianwei Zhang, Wenhua Wang, Xuefu Han, Meng Liu, Shujie Zhang, Wenjiu Feng, Yujie Wang, Yanbo Chen

Abstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Circulating miR-10b-5p as a candidate biomarker of atrial fibrillation recurrence after catheter ablation: a two-phase translational study.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lujing Nie *Department of Arrhythmia, Weifang People's Hospital, Shandong Second Medical University, Weifang, Shandong, China.
Tianwei Zhang *Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Wenhua WangDepartment of Arrhythmia, Weifang People's Hospital, Shandong Second Medical University, Weifang, Shandong, China.
Xuefu HanDepartment of Arrhythmia, Weifang People's Hospital, Shandong Second Medical University, Weifang, Shandong, China.
Meng LiuDepartment of Cardiology I, Weifang People's Hospital, Shandong Second Medical University, Weifang, Shandong, China.
Shujie ZhangDepartment of Arrhythmia, Weifang People's Hospital, Shandong Second Medical University, Weifang, Shandong, China.
Wenjiu FengDepartment of Arrhythmia, Weifang People's Hospital, Shandong Second Medical University, Weifang, Shandong, China.
Yujie WangDepartment of Cardiology, Changle People's Hospital, Weifang, Shandong, China.
Yanbo ChenDepartment of Arrhythmia, Weifang People's Hospital, Shandong Second Medical University, Weifang, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This study seeks to develop and validate a machine learning (ML) model for predicting atrial fibrillation (AF) recurrence at 12 months following radiofrequency catheter ablation (RFCA). Methods: A total of 430 consecutive patients with atrial fibrillation undergoing first-time radiofrequency catheter ablation were retrospectively enrolled between June 2022 and December 2023. Patients were randomly assigned to either a training cohort (70%) or a testing cohort (30%). Four ML algorithms were employed to develop prediction models. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC) and accuracy. The SHapley Additive exPlanations (SHAP) methodology was employed to interpret the best-performing model and quantify each feature's contribution to its predictions. Results: Among the four machine learning algorithms evaluated, the Light Gradient Boosting Machine (LightGBM) model showed promising predictive performance on the testing set, achieving an accuracy of 0.721 and an AUC of 0.848 (95% CI: 0.778-0.919). Interpretation of the LightGBM model using SHAP analysis identified B-type natriuretic peptide (BNP) and the neutrophil-to-lymphocyte ratio (NLR) as the most impactful predictors for AF recurrence. The analysis revealed that higher levels of BNP and NLR were strongly associated with an increased risk of recurrence, whereas higher levels of albumin and lymphocyte count were protective. Other significant predictors included left atrial diameter (LAD) and nonparoxysmal atrial fibrillation (NPAF). Conclusion: Machine learning-based models show modest but promising performance for assessing AF recurrence risk after RFCA using routine clinical data. While requiring extensive external validation before clinical application, these models highlight the potential of ML to inform future risk stratification and guide personalized follow-up strategies.

Indexed as

atrial fibrillationmachine learningprediction modelradiofrequency ablationrecurrence

Identifiers

PMID40860368
PMCPMC12370652

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.